Venture
TrialSpark, Inc.
Latest Form D 2024-07-02- CIK 2028122
- State NY
- Pharmaceuticals
- 1 Form D offering since 2024-07-02
- Total sold
- $372M
- across its one offering
- Rounds
- 1
- Form D offerings since 2024-07-02
- Latest round
- $372M
- 2024-07-02 · 021-517677
- Investors
- 16
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2024-07-02 · $372M
- 2024-07-02$372M021-517677
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($372M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-517677 | First filed2024-07-02 | Latest2024-07-02 | Sought$512M | Sold$372M | Investors16 | Exemptions506(b) |
Who backs TrialSpark, Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2024-07-02
| Name | Relationship |
|---|---|
| Benjamine Liu | RelationshipExecutive Officer, Director |
| Alfred Lin | RelationshipDirector |
| Scott Kupor | RelationshipDirector |
| Linhao Zhang | RelationshipExecutive Officer, Director |
| Michael Moritz | RelationshipDirector |
Facts
As its latest Form D states them
- Industry
- Pharmaceuticals
- State
- New York (NY)
- Exemptions
- Rule 506(b)
- First filed
- 2024-07-02
- Latest filing
- 2024-07-02
Who backs TrialSpark, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗